Pharmafile Logo

Reducing Carbon Footprint with Virtual Meetings – Perks of Virtual Medical Education

Discover how replacing in-person meetings with virtual alternatives can significantly cut carbon emissions and support environmental initiatives. Our latest video highlights the crucial role of virtual meetings in reducing the ecological impact of conferences. Join us in fostering a greener future!

Explore the environmental benefits of virtual meetings in our ninth video from the “Perks of Virtual Medical Education” series. Learn how shifting from in-person to virtual meetings can significantly reduce carbon emissions and support sustainability efforts.

9. The Environmental Footprint is Much Smaller with Virtual vs. In-Person Meetings The shift towards virtual meetings is not only a matter of convenience or cost but also a significant environmental decision. National and international in-person meetings often involve extensive travel that contributes to large carbon footprints. By incorporating virtual meetings, organizations can drastically cut down emissions associated with air travel and ground transportation. As the environmental movement gains momentum, and the pharmaceutical industry begins to embrace more sustainable practices, the preference for virtual participation continues to grow. Participants appreciate the option to engage from anywhere without the environmental cost of travel, and it is likely that such expectations will only increase in the future.

For more insights into how virtual meetings contribute to sustainability in medical education and beyond, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your sustainable engagement strategies with Impetus Digital:

Stay connected for more sustainable practices in medical education:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...

Scanning for Health Indicators and Risks Through Your Smartphone

Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging, dives into the implications of increased integration of tech and data into daily life for the...

Virtual MSL/Sales training programs and events

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...